Cargando…

Robotic versus Open Radical Cystectomy: An Updated Systematic Review and Meta-Analysis

OBJECTIVE: To critically review the currently available evidence of studies comparing robot-assisted radical cystectomy (RARC) with open radical cystectomy (ORC). METHODS: A comprehensive review of the literature from Pubmed, Web of Science and Scopus was performed in April 2014. All relevant studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Leilei, Wang, Xianjin, Xu, Tianyuan, Zhang, Xiaohua, Zhu, Zhaowei, Qin, Liang, Zhang, Xiang, Fang, Chen, Zhang, Minguang, Zhong, Shan, Shen, Zhoujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380496/
https://www.ncbi.nlm.nih.gov/pubmed/25825873
http://dx.doi.org/10.1371/journal.pone.0121032
Descripción
Sumario:OBJECTIVE: To critically review the currently available evidence of studies comparing robot-assisted radical cystectomy (RARC) with open radical cystectomy (ORC). METHODS: A comprehensive review of the literature from Pubmed, Web of Science and Scopus was performed in April 2014. All relevant studies comparing RARC with ORC were included for further screening. A pooled meta-analysis of all comparative studies was performed and publication bias was assessed by a funnel plot. RESULTS: Nineteen studies were included for the analysis, including a total of 1779 patients (787 patients in the RARC group and 992 patients in the ORC group). Although RARC was associated with longer operative time (p <0.0001), patients in this group might benefit from significantly lower overall perioperative complication rates within 30 days and 90 days (p = 0.005 and 0.0002, respectively), more lymph node yields (p = 0.009), less estimated blood loss (p <0.00001), lower need for perioperative and intraoperative transfusions (p <0.0001 and <0.0001, respectively), and shorter postoperative length of stay (p = 0.0002). There was no difference between two groups regarding positive surgical margin rates (p = 0.19). CONCLUSIONS: RARC appears to be an efficient alternative to ORC with advantages of less perioperative complications, more lymph node yields, less estimated blood loss, lower need for transfusions, and shorter postoperative length of stay. Further studies should be performed to compare the long-term oncologic outcomes between RARC and ORC.